BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 8792085)

  • 1. Regulatory and signaling properties of the Vav family.
    Bustelo XR
    Mol Cell Biol; 2000 Mar; 20(5):1461-77. PubMed ID: 10669724
    [No Abstract]   [Full Text] [Related]  

  • 2. Signalling pathways induced by protease-activated receptors and integrins in T cells.
    Bar-Shavit R; Maoz M; Yongjun Y; Groysman M; Dekel I; Katzav S
    Immunology; 2002 Jan; 105(1):35-46. PubMed ID: 11849313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity.
    Billadeau DD; Mackie SM; Schoon RA; Leibson PJ
    J Exp Med; 2000 Aug; 192(3):381-92. PubMed ID: 10934226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-stoichiometric reduced complexity probes for cDNA arrays.
    Trenkle T; Welsh J; Jung B; Mathieu-Daude F; McClelland M
    Nucleic Acids Res; 1998 Sep; 26(17):3883-91. PubMed ID: 9705494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.
    Uddin S; Yetter A; Katzav S; Hofmann C; White MF; Platanias LC
    Exp Hematol; 1996 Apr; 24(5):622-7. PubMed ID: 8605967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation.
    Groysman M; Nagano M; Shaanan B; Katzav S
    Oncogene; 1998 Sep; 17(12):1597-606. PubMed ID: 9794237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.
    Margolis B; Hu P; Katzav S; Li W; Oliver JM; Ullrich A; Weiss A; Schlessinger J
    Nature; 1992 Mar; 356(6364):71-4. PubMed ID: 1531699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vav: Captain Hook for signal transduction?
    Katzav S
    Crit Rev Oncog; 1995; 6(2):87-97. PubMed ID: 8792085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav: function and regulation in hematopoietic cell signaling.
    Bonnefoy-BĂ©rard N; Munshi A; Yron I; Wu S; Collins TL; Deckert M; Shalom-Barak T; Giampa L; Herbert E; Hernandez J; Meller N; Couture C; Altman A
    Stem Cells; 1996 May; 14(3):250-68. PubMed ID: 8724692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.
    Hu P; Margolis B; Schlessinger J
    Bioessays; 1993 Mar; 15(3):179-83. PubMed ID: 8489524
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.